<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:05:08Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/15088" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/15088</identifier><datestamp>2026-10-18T21:14:25Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Comparison of TIVA and desflurane added to a subanaesthetic dose of propofol in patients undergoing coronary artery bypass surgery: Evaluation of haemodynamic and stress hormone changes</dc:title><dc:creator>Onk, Didem</dc:creator><dc:creator>Ayazoglu, Tölin Akarsu</dc:creator><dc:creator>Onk, Oruç Alper</dc:creator><dc:creator>Aksöt, Mehmet</dc:creator><dc:creator>Gönay, Murat</dc:creator><dc:creator>Turkmen, Kultigin</dc:creator><dc:creator>Özensoy, Aynur</dc:creator><dc:creator>Ersoy, Çigdem Yazici</dc:creator><dc:creator>Çoban, Abdulkadir</dc:creator><dc:subject>Aged</dc:subject><dc:subject>Aged, 80 and over</dc:subject><dc:subject>Anesthesia, Intravenous</dc:subject><dc:subject>Anesthetics, Inhalation</dc:subject><dc:subject>Aorta</dc:subject><dc:subject>Biomarkers</dc:subject><dc:subject>Body Mass Index</dc:subject><dc:subject>Cardiopulmonary Bypass</dc:subject><dc:subject>Coronary Artery Bypass</dc:subject><dc:subject>Fentanyl</dc:subject><dc:subject>Hemodynamics</dc:subject><dc:subject>Hormones</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Isoflurane</dc:subject><dc:subject>Middle Aged</dc:subject><dc:subject>Myocardial Ischemia</dc:subject><dc:subject>Propofol</dc:subject><dc:subject>desflurane</dc:subject><dc:subject>glyceryl trinitrate</dc:subject><dc:subject>hydrocortisone</dc:subject><dc:subject>insulin</dc:subject><dc:subject>stress hormone</dc:subject><dc:subject>biological marker</dc:subject><dc:subject>hormone</dc:subject><dc:subject>inhalation anesthetic agent</dc:subject><dc:subject>adult</dc:subject><dc:subject>age</dc:subject><dc:subject>Article</dc:subject><dc:subject>body mass</dc:subject><dc:subject>clinical article</dc:subject><dc:description>Introduction. Increased levels of stress hormones are associated with mortality in patients undergoing coronary artery bypass grafting (CABG). Aim. To compare total intravenous anaesthesia (TIVA) and desflurane added to a subanaesthetic dose of propofol. Material and Methods. Fifty patients were enrolled in this study. Fentanyl (3-5mcg/kg/h) was started in both groups. Patients were divided into two groups. The PD group (n = 25) received 1 minimum alveolar concentration (MAC) desflurane anaesthesia in addition to propofol infusion (2-3mg/kg/h), while P group (n = 25) received propofol infusion (5-6mg/kg/h) only. Biochemical data, cortisol, and insulin levels were measured preoperatively (T0), after initiation of CPB but before cross-clamping the aorta (T1), after removal of the cross-clamp (T2), and at the 24th postoperative hour (T3). Results. Systolic, diastolic, and mean arterial pressure levels were significantly higher in PD group than those in P group in T1 and T2 measurements (p ≤ 0.05). CK-MB showed a significant decrease in group P (p ≤ 0.05).When we compared both groups, cortisol levels were significantly higher in PD group than P group (p ≤ 0.05). Conclusion. Stress and haemodynamic responses were better controlled using TIVA than desflurane inhalation added to a subanaesthetic dose of propofol in patients undergoing CABG. Copyright © 2016 Didem Onk et al.</dc:description><dc:publisher>Hindawi Limited</dc:publisher><dc:date>2016</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/15088</dc:identifier><dc:identifier>https://doi.org/10.1155/2016/3272530</dc:identifier><dc:identifier>2314-6133</dc:identifier><dc:language>en</dc:language><dc:relation>BioMed Research International</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/15088</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>